Establishing a new human pneumococcal standard reference serum, MPRSS-01
ABSTRACT Measuring the immunogenicity of pneumococcal vaccines involves the use of immunoassays to measure serotype-specific immunoglobulin G (IgG) antibody levels post-vaccination with the current Streptococcus pneumoniae human reference serum standard (007sp) for anti-pneumococcal capsule antibodi...
Saved in:
Main Authors: | Joseph M. Antonello, Rocio D. Murphy, Chitrananda Abeygunawardana, Juliana C. Malinverni, Rajam Gowrisankar, Tina Green, Rebecca Greway, Jenna Schmauch, Adrienne Howlett, Cyrille J. Bonhomme, Katrina M. Nolan |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2025-01-01
|
Series: | mSphere |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/msphere.00404-24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hospital burden of pneumococcal disease in Spain (2016–2022): A retrospective study
by: Ruth Gil-Prieto, et al.
Published: (2025-12-01) -
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015
by: Ting-An Yen, et al.
Published: (2025-02-01) -
Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status
by: Hasip Kahraman, et al.
Published: (2025-02-01) -
IAPSM’s Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India
by: Chythra R. Rao, et al.
Published: (2024-12-01) -
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
by: Alane Izu, et al.
Published: (2025-12-01)